Project Grant HT94252410533
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$132K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $1,560,218 Project Grant under the Military Medical Research and Development (CFDA 12.420) program from the Defense Health Agency. The grant, awarded on September 30, 2025, supports a randomized clinical trial to investigate strategies for reducing aggression in military personnel. UTHSCSA, a prominent Hispanic-serving academic medical center, has extensive expertise in serving military and veteran populations...
This Project Grant award of $541,658.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports targeted auditory plasticity training to improve central hearing in mild traumatic brain injury (TBI). The primary awardee is The University of Texas at San Antonio (UTSA), a Hispanic-serving research university. UTSA will collaborate with Northeastern University on this project, which involves customizing an auditory...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $6,133,100 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 4-year research project to develop and validate personalized treatment models for persistent headaches attributable to mild traumatic brain injury in U.S. military service members and veterans. The research includes specifying and validating patient-centered models...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $433,126 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to explore the role of PACAP38 in post-traumatic headache. The award period runs from January 1, 2025 to December 31, 2027. UTHSCSA, a prominent Hispanic-serving academic medical center, has extensive expertise in medical research and has received numerous grants from...
This federal Project Grant award of $3,150,000, awarded on September 30, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The grantee, The University of Texas Health Science Center at San Antonio (UTHSCSA), is a prominent academic...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $1,565,298 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETING METTL3 TO OVERCOME DRUG RESISTANCE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA," is focused on advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. UTHSCSA, a...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $1,181,251 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2025, will fund the development and evaluation of a Computerized Anger Management Protocol (CAMP) for service members with and without a history of mild traumatic brain injury. The project aims to create an innovative digital therapeutic solution to...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $1,872,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The 3-year grant, awarded on June 1, 2025, supports advanced biomedical research to develop the anti-prostate cancer agent Selisistat for the treatment of prostate cancer. As a prominent Hispanic-serving academic medical center, UTHSCSA has extensive expertise in...